Accessibility Menu

Bioxyne

(ASX) BLS

Current PriceA$0.90
Market CapA$206.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)-32%
5 Year+200%
1 Year+120%
1 Month+5%

Bioxyne Financials at a Glance

Market Cap

A$206.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

A$0.04

P/E Ratio

22.17

Dividend

A$0.00

Beta (Volatility)

-0.11 (Low)

Price

A$0.90

Volume

561,579

Open

A$0.85

Previous Close

A$0.90

Daily Range

A$0.82 - A$0.93

52-Week Range

A$0.33 - A$1.10

Estimated Earnings Date

N/A

BLS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bioxyne

Industry

Life Sciences Tools and Services

CEO

Sam Watson

BLS Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

65.19%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.51%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

A$206.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

229.10M

Volume

561.58K

Avg. Volume

402.27K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Bioxyne Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

A$206.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,570.77+0.00%
^DJIDJI
$52,660.66+0.00%
^IXICNASDAQ
$26,285.09+0.00%
BTCBitcoin
$63,842.00+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$18.78+0.01%
AALAmerican Airlines Group
$16.95-0.01%
PATHUiPath
$11.68-0.01%
FRMIFermi
$6.59-0.10%

Questions About BLS

What is the current price of Bioxyne?

Bioxyne is trading at A$0.90 per share.

What is the 52-week range for Bioxyne?

Over the past 52 weeks, Bioxyne has traded between A$0.33 and A$1.10.

How much debt does Bioxyne have?

As of the most recent reporting period, Bioxyne reported total debt of A$1.53M.

How much cash does Bioxyne have on hand?

Bioxyne reported A$7.67M in cash and cash equivalents in its most recent financial results.

What is Bioxyne’s dividend yield?

Bioxyne does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.